Defiance Daily Target 2X Long MRNA ETF (MRNX)
NYSEARCA: MRNX · Real-Time Price · USD
31.05
+2.02 (6.94%)
Feb 27, 2026, 4:00 PM EST - Market closed
6.94% (1D)
| Assets | n/a |
| Expense Ratio | 1.31% |
| PE Ratio | n/a |
| Shares Out | 30,000 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 3,624 |
| Open | 28.99 |
| Previous Close | 29.03 |
| Day's Range | 28.78 - 31.05 |
| 52-Week Low | 14.95 |
| 52-Week High | 31.61 |
| Beta | n/a |
| Holdings | n/a |
| Inception Date | Feb 3, 2026 |
About MRNX
Fund Home PageThe Defiance Daily Target 2X Long MRNA ETF (MRNX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of Moderna, Inc. (NASDAQ: MRNA), net fees and expenses, through derivatives like swap agreements MRNX was launched on Feb 3, 2026 and is issued by Defiance.
News
Defiance Launches MRNX: The First Daily 2X Long ETF for Moderna, Inc.
MIAMI, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs today announced the launch of the Defiance Daily Target 2X Long MRNA ETF (MRNX) , expanding its lineup of single-stock leveraged ETFs designed f...
Other symbols: MRNA
24 days ago - GlobeNewsWire